January 15, 2025
TOPLINE: A study identified significant differences in the scalp microbiome composition of women with central centrifugal cicatricial alopecia (CCCA) compared with controls, particularly with significantly higher […]
January 15, 2025
NEW YORK — Targeted at fundamental processes that control skin aging, several therapies are currently being tested for the promise of a regulatory-granted antiaging indication, according […]
January 10, 2025
Chronic pruritus is a common problem among older individuals. During a session at the Dermatology Days of Paris 2024 conference dedicated to general practitioners, Juliette Delaunay, […]
January 8, 2025
TOPLINE: Merkel cell carcinoma (MCC) is less common and is associated with higher mortality rates than melanoma, according to a study that also reported that male […]
January 7, 2025
TOPLINE: The newer biologics — interleukin (IL)-17, IL-12/23, and IL-23 inhibitors — demonstrate comparable cardiovascular safety profiles to tumor necrosis factor (TNF) inhibitors in biologic-naive patients […]
January 6, 2025
NEW YORK — Topical antifungals should no longer be considered a first-line therapy for seborrheic dermatitis for two reasons: Topical anti-inflammatories have replaced them, and rates […]
January 2, 2025
NEW YORK — The idea of having dermatologists and rheumatologists under one roof to see patients with psoriasis prone to psoriatic arthritis (PsA) — a concept […]
December 30, 2024
TOPLINE: Tildrakizumab was well tolerated and achieved sustained response in patients with moderate to severe plaque psoriasis of the scalp in a phase 3 study. METHODOLOGY: […]
December 30, 2024
For over 200 years, researchers have been captivated by axolotl salamanders (Ambystoma mexicanum) and their remarkable regenerative abilities, seeking to uncover secrets that could revolutionize regenerative […]